September 30, 2025 - 19:30

Artemis Capital Partners, a private equity firm located in Boston, has announced its acquisition of Millrock Technology, a company known for its innovative solutions in the industrial technology sector. This strategic move aims to enhance Artemis's portfolio by integrating Millrock's advanced capabilities and expertise into its operations.
Millrock Technology specializes in providing cutting-edge products and services that cater to various industrial applications, positioning itself as a leader in the tech-driven industrial landscape. The acquisition is expected to create synergies between the two organizations, allowing for enhanced research and development initiatives and improved market offerings.
The leadership at Artemis believes that this acquisition will not only strengthen their competitive edge but also contribute to the growth and innovation within the industrial technology space. By combining resources and expertise, the partnership aims to drive efficiency and deliver superior solutions to clients, further solidifying both companies' positions in the market. This acquisition reflects Artemis's commitment to investing in companies that are at the forefront of technological advancement.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...